Latest Market Strategy News

Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.

Fenix Resources’ latest Scoping Study outlines a robust plan to ramp up Weld Range iron ore production to 10 million tonnes per annum by 2031, extending mine life to 2042 with significantly reduced costs and strong financial returns.

SportsHero Limited’s new HeroPlay mobile gaming platform is off to a strong start in Indonesia, attracting nearly 300 daily subscribers and generating early revenue that validates its market strategy.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Ovanti’s US payments brand Flote has partnered with cloud-native platform Gr4vy to launch scalable, responsible buy now pay later solutions in the US market starting 2026.

Locksley Resources has launched an Expression of Interest process to select a leading U.S. engineering firm for the Desert Antimony Mine pilot plant design, marking a critical step toward establishing a domestic antimony supply chain aligned with federal priorities.

Yari Minerals has completed four drillholes at its Rolleston South Coal Project, confirming thick, continuous coal seams and progressing towards upgrading part of its 190.1 Mt Inferred Resource to Indicated status.

Linius Technologies, soon to be Ion Video Limited, appoints Sophie Karzis as company secretary and Canaccord Genuity as corporate advisor, signaling a strategic push in governance and capital markets engagement.

Ovanti Limited’s U.S. BNPL arm, Flote, has signed a Letter of Intent with Nasdaq-listed Miluna Acquisition Corp for a $300 million valuation, aiming for a Nasdaq listing while preserving Ovanti’s majority ownership.

Prophecy International Holdings reports a modest revenue dip and net loss in FY25, cancels its Complexica merger, and pivots to AI-driven product innovation and cost control.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.

Locksley Resources has kicked off its maiden drilling at the El Campo Rare Earths Prospect and secured full regulatory approval for an expanded program at the Desert Antimony Mine, setting the stage for continuous exploration updates through mid-2026.